Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Aarts BM, Gomez FM, Lopez-Yurda M, Bevers RFM, et al. Eur Radiol 2023;33:1040-1049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aarts BM, Gomez FM, Lopez-Yurda M, Bevers RFM, et al. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Eur Radiol 2023;33:1040-1049.
PMID: 36066733